REPRISE BIOMEDICAL, INC. – Trademark Portfolio

Entity Type: 03

REPRISE BIOMEDICAL, INC. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 6 trademarks are registered and 3 are pending. Notable registered marks include MIRO3D, MIRODRY, MIRODERM, MIROFLEX, and MIROTRACT. The owner is based in PLYMOUTH, MN.

17400 MEDINA ROAD

SUITE 100

PLYMOUTH, MN 55447

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

REPRISE BIOMEDICAL, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (10 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does REPRISE BIOMEDICAL, INC. have?

REPRISE BIOMEDICAL, INC. has 10 U.S. trademarks filed with the USPTO. Of these, 6 registered, 3 pending, 1 cancelled.

What trademark classes does REPRISE BIOMEDICAL, INC. file in?

REPRISE BIOMEDICAL, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are REPRISE BIOMEDICAL, INC.'s most well-known trademarks?

REPRISE BIOMEDICAL, INC.'s registered trademark portfolio includes well-known marks such as MIRO3D, MIRODRY, MIRODERM, MIROFLEX, and MIROTRACT. These are among 6 currently registered trademarks in the portfolio.

What is REPRISE BIOMEDICAL, INC.'s trademark registration success rate?

REPRISE BIOMEDICAL, INC. has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 3 applications are pending review.